BioStem Technologies, Inc. Clinical Trials
Studies registered on ClinicalTrials.gov (U.S. National Library of Medicine) with the company as lead sponsor or collaborator, newest start first. Values are as registered.
- 2025-02-14: Study NCT06811909; Company role Lead sponsor; Phase Not applicable; Status Active not recruiting.
- 2024-10-28: Study NCT06565156; Company role Lead sponsor; Phase Not applicable; Status Completed.
- 2024-09-03: Study NCT06511596; Company role Lead sponsor; Phase Not applicable; Status Completed.
- 2024-01-15: Study NCT06150209; Company role Lead sponsor; Phase Not applicable; Status Unknown.
| Start date | Study | Company role | Phase | Status | Conditions | Enrollment | Completion date |
|---|---|---|---|---|---|---|---|
| 2025-02-14 | NCT06811909 Non-healing Venous Leg Ulcers Treated With Standard Care With or Without BR-AC | Lead sponsor | Not applicable | Active not recruiting | Non-infected Venous Leg Ulcer; Venous Leg Ulcer; Venous Insufficiency; Venous Stasis; Venous Reflux | 71 | 2026-10 |
| 2024-10-28 | NCT06565156 Non-healing Diabetic Foot Ulcers Treated With Standard Care With or Without BR-AM | Lead sponsor | Not applicable | Completed | Non-infected Diabetic Foot Ulcer; Diabetic Foot; Diabetic Wound; Diabetic Foot Ulcer; Non-ischemic Diabetic Foot Ulcer | 72 | 2026-04-30 |
| 2024-09-03 | NCT06511596 A Prospective Trial of Non-healing Diabetic Foot Ulcers Treated With Standard Care With or Without BR-AC | Lead sponsor | Not applicable | Completed | Diabetic Foot Ulcer | 71 | 2025-12-22 |
| 2024-01-15 | NCT06150209 A Controlled Prospective Treatment Study to Evaluate the Efficacy of Vendaje. | Lead sponsor | Not applicable | Unknown | Diabetic Foot Ulcer | 100 | 2025-06-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |